ATE229344T1 - Impfstoff enthaltend lebendes virus - Google Patents

Impfstoff enthaltend lebendes virus

Info

Publication number: ATE229344T1
Authority: AT; Austria
Prior art keywords: virus; avian; human; lyophilization; purifying
Prior art date: 1992-03-24

Application number

AT93908381T

Other languages

English (en)

Inventor

Laszlo K Csatary

Original Assignee

United Cancer Res Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-03-24

Filing date

1993-03-23

Publication date

2002-12-15

1992-03-24 Priority claimed from HU9200966A external-priority patent/HU207297B/hu

1993-03-23 Application filed by United Cancer Res Inst filed Critical United Cancer Res Inst

2002-12-15 Application granted granted Critical

2002-12-15 Publication of ATE229344T1 publication Critical patent/ATE229344T1/de

Links

241000700605 Viruses Species 0.000 title abstract 7
229960005486 vaccine Drugs 0.000 title abstract 3
241000271566 Aves Species 0.000 abstract 6
238000004108 freeze drying Methods 0.000 abstract 2
241000711404 Avian avulavirus 1 Species 0.000 abstract 1
206010006811 Bursitis Diseases 0.000 abstract 1
241000701047 Gallid alphaherpesvirus 2 Species 0.000 abstract 1
241000282414 Homo sapiens Species 0.000 abstract 1
241000598171 Human adenovirus sp. Species 0.000 abstract 1
241000484121 Human parvovirus Species 0.000 abstract 1
229920001612 Hydroxyethyl starch Polymers 0.000 abstract 1
229920000881 Modified starch Polymers 0.000 abstract 1
239000004368 Modified starch Substances 0.000 abstract 1
241000125945 Protoparvovirus Species 0.000 abstract 1
241000702670 Rotavirus Species 0.000 abstract 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
229930006000 Sucrose Natural products 0.000 abstract 1
206010006451 bronchitis Diseases 0.000 abstract 1
238000005119 centrifugation Methods 0.000 abstract 1
239000000084 colloidal system Substances 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
206010014599 encephalitis Diseases 0.000 abstract 1
239000012530 fluid Substances 0.000 abstract 1
229940050526 hydroxyethylstarch Drugs 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
235000019426 modified starch Nutrition 0.000 abstract 1
239000008188 pellet Substances 0.000 abstract 1
230000001681 protective effect Effects 0.000 abstract 1
239000005720 sucrose Substances 0.000 abstract 1
239000006228 supernatant Substances 0.000 abstract 1
238000005199 ultracentrifugation Methods 0.000 abstract 1
241001529453 unidentified herpesvirus Species 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10051—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Public Health (AREA)
Microbiology (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Mycology (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT93908381T 1992-03-24 1993-03-23 Impfstoff enthaltend lebendes virus ATE229344T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
HU9200966A HU207297B (en)	1992-03-24	1992-03-24	Process for producing 4-hydroxy-7-chloro-quinoline
HU9226547		1992-08-17
PCT/US1993/002441 WO1993018790A1 (en)	1992-03-24	1993-03-23	Vaccine containing live virus for therapy of viral diseases and malignancies

Publications (1)

Publication Number	Publication Date
ATE229344T1 true ATE229344T1 (de)	2002-12-15

Family

ID=26318074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93908381T ATE229344T1 (de)	1992-03-24	1993-03-23	Impfstoff enthaltend lebendes virus

Country Status (10)

Country	Link
EP (1)	EP0713397B1 (de)
KR (1)	KR950700756A (de)
AT (1)	ATE229344T1 (de)
AU (1)	AU673827B2 (de)
CA (1)	CA2132328C (de)
DE (1)	DE69332566T2 (de)
DK (1)	DK0713397T3 (de)
ES (1)	ES2188593T3 (de)
PT (1)	PT713397E (de)
WO (1)	WO1993018790A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2310580T3 (es)	1993-04-30	2009-01-16	Wellstat Biologics Corporation	Composiciones purificadas del virus de la enfermedad de newcastle.
DE4422238C2 (de) *	1994-06-24	1996-05-30	Behringwerke Ag	Verfahren zur Isolierung einer Antigenpräparation
EP0968284B1 (de)	1996-11-20	2006-12-13	Introgen Therapeutics, Inc.	Ein verbessertes verfahren zur produktion und reinigung von adenoviralen vektoren
US7732129B1 (en)	1998-12-01	2010-06-08	Crucell Holland B.V.	Method for the production and purification of adenoviral vectors
US20030044384A1 (en)	1997-10-09	2003-03-06	Pro-Virus, Inc.	Treatment of neoplasms with viruses
US7780962B2 (en)	1997-10-09	2010-08-24	Wellstat Biologics Corporation	Treatment of neoplasms with RNA viruses
US7470426B1 (en)	1997-10-09	2008-12-30	Wellstat Biologics Corporation	Treatment of neoplasms with viruses
GB9808922D0 (en)	1998-04-24	1998-06-24	Cantab Pharmaceuticals Res Ltd	Virus preparations
EP1133316B1 (de) *	1998-11-16	2009-01-21	Introgen Therapeutics, Inc.	Adenovirus-formulierungen zur gentherapie
US6689600B1 (en)	1998-11-16	2004-02-10	Introgen Therapeutics, Inc.	Formulation of adenovirus for gene therapy
CN1477964A (zh)	1999-04-15	2004-02-25		应用病毒治疗肿瘤
US8147822B1 (en)	1999-09-17	2012-04-03	Wellstat Biologics Corporation	Oncolytic virus
AU782402B2 (en)	1999-09-17	2005-07-28	Wellstat Biologics Corporation	Oncolytic virus
WO2005066333A1 (en) *	2003-12-30	2005-07-21	Aventis Pasteur, Inc.	Stabilizing compositions for recombinant viruses
WO2005071067A2 (en)	2004-01-15	2005-08-04	Intervet International B.V.	Non-animal origin stabilizers and processes for producing the same
CN101080488A (zh)	2004-11-03	2007-11-28	因特罗根治疗公司	生产和纯化腺病毒载体的新方法
PL2278002T3 (pl)	2005-07-29	2017-12-29	Abbott Laboratories Gmbh	Pankreatyna o zmniejszonej zawartości wirusowej
US9198871B2 (en)	2005-08-15	2015-12-01	Abbott Products Gmbh	Delayed release pancreatin compositions
US11266607B2 (en)	2005-08-15	2022-03-08	AbbVie Pharmaceuticals GmbH	Process for the manufacture and use of pancreatin micropellet cores
US10072256B2 (en)	2006-05-22	2018-09-11	Abbott Products Gmbh	Process for separating and determining the viral load in a pancreatin sample
EP2327764B1 (de)	2009-11-30	2011-12-28	United Cancer Research Institute	Neuer Klon des Geflügelpestvirus, Herstellung und Anwendung bei der medizinischen Behandlung von Krebs
MX373096B (es)	2010-12-02	2020-04-27	Oncolytics Biotech Inc	Formulaciones virales líquidas.
CA2819236A1 (en)	2010-12-02	2012-06-07	Oncolytics Biotech Inc.	Lyophilized viral formulations
EP4499051A1 (de) *	2022-03-30	2025-02-05	Bioneedle Drug Delivery B.V.	Verfahren zur lagerung biologisch aktiver konstrukte in einem biologisch abbaubaren material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4158054A (en) *	1973-10-18	1979-06-12	Duncan Flockhart & Co. Ltd.	Preparation of virus sub-unit vaccines
US3874999A (en) *	1973-10-31	1975-04-01	American Cyanamid Co	Process for the purification of virus vaccine
BE853923A (fr) *	1977-04-25	1977-10-25	Rit Rech Ind Therapeut	Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
US4457916A (en) *	1982-08-31	1984-07-03	Asahi Kasei Kogyo Kabushiki Kaisha	Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
GB8324800D0 (en) *	1983-09-15	1983-10-19	Pasteur Institut	Antigens
HU197846B (en) *	1984-07-02	1989-06-28	Laszlo Csatary	Process for producing therapeutic composition suitable for treating virus infections
HU197517B (en) *	1984-07-30	1989-04-28	Laszlo Csatary	Process for production of terapeutical composition applicable against virus infection
DD229031A1 (de) *	1984-11-19	1985-10-30	Fi Fuer Lungenkrankheiten Und	Verfahren zur herstellung eines oral-impfstoffes
EP0318498B1 (de) *	1986-08-04	1993-03-03	THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce	Menschlicher b-lymphotroper virus (hblv), isolierung und erzeugnisse
US4824668A (en) *	1987-03-09	1989-04-25	Sterwin Laboratories Inc.	Attenuated infectious bursal disease virus strain and vaccine therefrom
US5124148A (en) *	1988-04-27	1992-06-23	United Cancer Research Institute	Method for treating viral diseases with attenuated virus
AU663290B2 (en) *	1990-05-21	1995-10-05	The Administrators Of The Tulane Eductional Fund	Association between a human immunodeficiency virus-related retrovirus and Sjogren's syndrome

1993
- 1993-03-23 ES ES93908381T patent/ES2188593T3/es not_active Expired - Lifetime
- 1993-03-23 CA CA002132328A patent/CA2132328C/en not_active Expired - Fee Related
- 1993-03-23 DE DE69332566T patent/DE69332566T2/de not_active Expired - Fee Related
- 1993-03-23 WO PCT/US1993/002441 patent/WO1993018790A1/en not_active Ceased
- 1993-03-23 PT PT93908381T patent/PT713397E/pt unknown
- 1993-03-23 DK DK93908381T patent/DK0713397T3/da active
- 1993-03-23 AU AU39222/93A patent/AU673827B2/en not_active Ceased
- 1993-03-23 EP EP93908381A patent/EP0713397B1/de not_active Expired - Lifetime
- 1993-03-23 AT AT93908381T patent/ATE229344T1/de not_active IP Right Cessation
1994
- 1994-09-23 KR KR1019940703303A patent/KR950700756A/ko not_active Ceased

Also Published As

Publication number	Publication date
DE69332566D1 (de)	2003-01-23
CA2132328C (en)	2000-10-31
PT713397E (pt)	2003-04-30
WO1993018790A1 (en)	1993-09-30
EP0713397A4 (de)	1995-12-07
EP0713397B1 (de)	2002-12-11
EP0713397A1 (de)	1996-05-29
KR950700756A (ko)	1995-02-20
CA2132328A1 (en)	1993-09-30
DK0713397T3 (da)	2003-03-31
AU3922293A (en)	1993-10-21
DE69332566T2 (de)	2003-09-04
AU673827B2 (en)	1996-11-28
ES2188593T3 (es)	2003-07-01

Legal Events

Date

Code

Title

Description

2003-07-15

UEP

Publication of translation of european patent specification

Ref document number: 0713397

Country of ref document: EP

2007-12-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DK0713397T3 (da)	2003-03-31	Vaccine indeholdende levende virus
CA1331444C (en)	1994-08-16	Ibdv production in continuous lines
US4317811A (en)	1982-03-02	Herpes simplex type 1 subunit vaccine
DE68915165D1 (de)	1994-06-09	Schimärische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
KR100475427B1 (ko)	2005-03-10	합성 ｒｎａ 전사체로부터 버나바이러스를 생산하는 방법
DE3689622D1 (de)	1994-03-17	Impfstoffe gegen menschliche respiratorische viren.
US4302444A (en)	1981-11-24	Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines
Kelly et al.	1974	Fowl plague virus replication in mammalian cell-avian erythrocyte heterokaryons: Studies concerning the actinomycin D and ultra-violet light sensitive phase in influenza virus replication
CA2181862A1 (en)	1997-02-02	Mild newcastle disease virus vaccine
US4946676A (en)	1990-08-07	Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
Cox	1982	The structural proteins of rabies virus
RU2142816C1 (ru)	1999-12-20	Способ получения антигерпетической вакцины и лекарственная форма на ее основе
Galabov	1981	[28] Induction and characterization of tortoise interferon
US4540669A (en)	1985-09-10	Herpes simplex type I subunit vaccine
US4213965A (en)	1980-07-22	Small-plaque variant canine herpesvirus vaccine
AU2002360659B2 (en)	2009-01-08	An avian embryo particulate biomass for the production of virus antigens
RU2195959C1 (ru)	2003-01-10	Инактивированная вакцина против синдрома гидроперикардита кур
Ibrahim et al.	2000	Paramyxovirus infection in pigeons
RU2199342C1 (ru)	2003-02-27	Способ изготовления инактивированной вакцины против синдрома гидроперикардита кур
RU2193062C1 (ru)	2002-11-20	Штамм кр 95 № 114 вируса синдрома гидроперикардита кур для изготовления вакцинных препаратов
Hubálek	1986	Some physical and chemical properties of Bhanja virus
PAYNE	1984	STUDIES ON ACUTE AND LATENT HERPES SIMPLEX VIRUS TYPE 1 INFECTIONS AND THE INFLUENCE OF SERUM IMMUNOGLOBULINS.
TH12563A (th)	1993-05-10	วีคซีนป้องกันไวรัสโรคมาเร็คชนิดปราศจากเซลล์
TH12049B (th)	2002-02-25	วีคซีนป้องกันไวรัสโรคมาเร็คชนิดปราศจากเซลล์
Xiaobin et al.	1992	Analysis of the Antigens of Detergent Disrupted Bovine Ephemeral Fever Virus